UNSPSC 51313511: Trenizine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WPQ720NCK. European Medicines Agency schedules Trenizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11234MIG. Trenizine generally arises in the molecular formula C31H40N2O.

UNSPSC 51313511 Trenizine is a Commodity code that names pharmaceutical products, but recent state and local solicitations tagged under this code actually cover a much broader range of health-supply procurement — naloxone and drug deactivation systems, generic pharmaceuticals distributed through state cooperative purchasing agreements, and direct-to-manufacturer prescription program capabilities. State and local governments buying under this code seek manufacturers and suppliers of emergency medical countermeasures, multi-source generic drugs, and related pharmacy services. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon). The code does not show a tight thematic focus — the recent opportunities span emergency response supplies, routine generic pharmaceutical procurement, and strategic pharmacy contracting approaches rather than a single product or service line.

Activity appears concentrated in the South and Upper Midwest, with recent solicitations from Florida, Texas, and Minnesota-led multistate purchasing. Seminole County issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 (note: date discrepancy in source). The Minnesota Multistate Cooperative Purchasing Alliance posted RFP S1070000015802 in January 2026 to establish multi-award contracts for generic pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs for a future formal procurement. These opportunities reflect distinct procurement models — emergency supply procurement, cooperative multistate drug purchasing, and strategic pharmacy benefit program design — rather than a unified commodity.